A child is vaccinated against malaria on September 13, 2019 in Ndhiwa, Homabaya County, Western Kenya during the launch of a malaria vaccine in Kenya. The vaccine (Mosquirix) is the world's first malaria vaccine that has been shown to provide partial protection against malaria in young children and has been rolled out by World Health Organization in Kenya, Ghana and Malawi. (Photo by Brian ONGORO / AFP) (Photo by BRIAN ONGORO/AFP via Getty Images) AFP via Getty Images

A late stage trial for an investigational malaria drug called GanLum (ganaplacide/lumefantrine) has demonstrated a 97.4% cure rate, outperforming currently existing treatments. The drug is being developed by the pharmaceutical firm Novartis in collaboration with a not-for-profit foundation called the Medicines for Malari

See Full Page